Dare Bioscience (DARE) Capital Leases (2025)

Dare Bioscience's (DARE) quarterly Capital Leases came in at $165186.0 in Q3 2025, little changed on a QoQ basis from $164412.0 in Q2 2025.

Dare Bioscience (DARE) Capital Leases (2025) Analysis & Trends

Dare Bioscience (DARE) has 1 years of Capital Leases data on file, last reported at $165186.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.65 Bn	131.79 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.08 Bn	78.09 Bn	3.93 Bn
3	Argenx Se	65.16 Bn	59.98 Bn	1.37 Bn
4	Moderna	63.25 Bn	58.11 Bn	52.00 Mn
5	BeOne Medicines	42.22 Bn	37.12 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.26 Bn	27.95 Bn	992.69 Mn
7	BioNTech SE	28.96 Bn	10.57 Bn	668.28 Mn
8	Insmed	27.40 Bn	26.24 Bn	358.27 Mn
9	Royalty Pharma	27.19 Bn	26.35 Bn	-
10	Dare Bioscience	12.06 Mn	-556,830.04	-132,343.00

Download Data